Analysed ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) News Sources
Top 100 Stocks to Buy: Two Penny Stocks Moved Up 51 Spots. Should You Buy Either?
04-11-2025
barchart.com
ESLA: Initiating Coverage of Estrella Immunopharma: A Potential Successor to Arcellx in Next-Generation CAR-T
18-03-2026
yahoo.com
Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
11-08-2026
yahoo.com
ESLA: Can Next-Generation CAR-T Therapy Improve Disease Control in Extranodal Lymphoma?
14-07-2026
yahoo.com
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma
24-07-2026
yahoo.com
Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
29-07-2026
yahoo.com
Estrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
03-08-2026
yahoo.com
What is the current price of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)?
The current price of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) is $0.7247.
ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) since the previous trading day is $-0.0003.
ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) since the previous trading day is -0.0414%.
What is the most recent average sentiment score for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)?
The most recent average sentiment score for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)?
The most recent sentiment for ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ) is .
SEC-8K** Filing Available For ESTRELLA IMMUNOPHARMA INC (ESLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.